Cancer cell resistance against the clinically investigated thiosemicarbazone COTI-2 is based on formation of intracellular copper complex glutathione adducts and …
JH Bormio Nunes, S Hager, M Mathuber… - Journal of medicinal …, 2020 - ACS Publications
COTI-2 is a novel anticancer thiosemicarbazone in phase I clinical trial. However, the effects
of metal complexation (a main characteristic of thiosemicarbazones) and acquired …
of metal complexation (a main characteristic of thiosemicarbazones) and acquired …
Inhibitor compounds and cancer treatment methods
WR Danter - US Patent 8,138,191, 2012 - Google Patents
0 [1*]/C ([2*])= N/N ([12*]) C (= S) CN1C ([3*])([4*]) C ([5*])([6*])[Y]([7*]) C ([8*])([9*]) C1
([10*])[11*] Chemical compound [1*]/C ([2*])= N/N ([12*]) C (= S) CN1C ([3*])([4*]) C …
([10*])[11*] Chemical compound [1*]/C ([2*])= N/N ([12*]) C (= S) CN1C ([3*])([4*]) C …
Compounds and method for treatment of cancer
WR Danter, M Brown, F Lepifre - US Patent 8,367,675, 2013 - Google Patents
US8367675B2 - Compounds and method for treatment of cancer - Google Patents
US8367675B2 - Compounds and method for treatment of cancer - Google Patents …
US8367675B2 - Compounds and method for treatment of cancer - Google Patents …
Inhibitor compounds and cancer treatment methods
WR Danter - US Patent 8,580,792, 2013 - Google Patents
US8580792B2 - Inhibitor compounds and cancer treatment methods - Google Patents
US8580792B2 - Inhibitor compounds and cancer treatment methods - Google Patents Inhibitor …
US8580792B2 - Inhibitor compounds and cancer treatment methods - Google Patents Inhibitor …
Compounds and method for treatment of cancer
WR Danter, M Brown, F Lepifre - US Patent 8,420,643, 2013 - Google Patents
US8420643B2 - Compounds and method for treatment of cancer - Google Patents
US8420643B2 - Compounds and method for treatment of cancer - Google Patents …
US8420643B2 - Compounds and method for treatment of cancer - Google Patents …
Compounds and method for treatment of cancer
WR Danter, CKK Lau - US Patent 8,466,151, 2013 - Google Patents
The invention relates to a compound of Formula (I) and/or a pharmaceutically-acceptable
salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof …
salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof …
Polymer drug conjugates with tether groups for controlled drug delivery
5,424,186 A 6, 1995 Fodor et al. 7,358,262 B2 4/2008 Stockwell 5.438, 072 A 8, 1995
Bobee et al. 7,375,096 B1 5/2008 Davis et al. 5.439, 686 A 8, 1995 Desai et al. 7.427, 605 …
Bobee et al. 7,375,096 B1 5/2008 Davis et al. 5.439, 686 A 8, 1995 Desai et al. 7.427, 605 …
Compounds and method for treatment of cancer
WR Danter, CK Lau - US Patent 8,895,556, 2014 - Google Patents
2.8 A 88: Willian et al. and/or a pharmaceutically-acceptable salt, hydrate, Solvate, 4.74 s.
160 A 5, 1988 Bennion et al. tautomer, optical isomer, E-isomer, Z-isomer, or combination …
160 A 5, 1988 Bennion et al. tautomer, optical isomer, E-isomer, Z-isomer, or combination …
Methods of detecting and treating a tumor expressing pT346 PDK1
DC Altieri - US Patent 11,208,478, 2021 - Google Patents
Cox, The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl
oxidase, Nature, 2015, vol. 522, pp. 106-110. Keith, HIFla and HIF2a: sibling rivalry in …
oxidase, Nature, 2015, vol. 522, pp. 106-110. Keith, HIFla and HIF2a: sibling rivalry in …
Inhibitor compounds and cancer treatment methods
WR Danter - US Patent 9,284,275, 2016 - Google Patents
US9284275B2 - Inhibitor compounds and cancer treatment methods - Google Patents
US9284275B2 - Inhibitor compounds and cancer treatment methods - Google Patents Inhibitor …
US9284275B2 - Inhibitor compounds and cancer treatment methods - Google Patents Inhibitor …